GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses
Sign Up to like & getrecommendations! Published in 2017 at "Bone Marrow Transplantation"
DOI: 10.1038/bmt.2016.305
Abstract: Allogeneic stem cell transplantation (alloSCT) is used for treating patients with T-prolymphocytic leukemia (T-PLL). However, direct evidence of GvL activity in T-PLL is lacking. We correlated minimal residual disease (MRD) kinetics with immune interventions and… read more here.
Keywords: mrd; mrd kinetics; evidence; prolymphocytic leukemia ... See more keywords